Entera Bio Ownership | Who Owns Entera Bio?
Entera Bio Ownership Summary
Entera Bio is owned by 23.54% institutional investors, 24.31% insiders, and 52.15% retail investors. Knoll capital management is the largest institutional shareholder, holding 13.56% of ENTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Entera Bio shares.
ENTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Entera Bio | 23.54% | 24.31% | 52.15% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Knoll capital management | 5.88M | 13.56% | $11.18M |
| Point72 asset management | 2.70M | 6.22% | $5.12M |
| Schonfeld strategic advisors | 632.31K | 1.68% | $1.34M |
| Parkman healthcare partners | 355.82K | 0.82% | $676.06K |
| Bessemer group | 140.84K | 0.32% | $268.00K |
| Renaissance | 61.80K | 0.16% | $131.02K |
| Signature estate & investment advisors | 47.33K | 0.11% | $89.92K |
| Susquehanna group, llp | 38.40K | 0.10% | $80.25K |
| Geode capital management | 21.14K | 0.06% | $44.17K |
| Hightower advisors | 11.83K | 0.03% | $25.08K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Knoll capital management | 5.88M | 7.95% | $11.18M |
| Parkman healthcare partners | 355.82K | 0.08% | $676.06K |
| Point72 asset management | 2.70M | 0.01% | $5.12M |
| Schonfeld strategic advisors | 632.31K | 0.01% | $1.34M |
| Signature estate & investment advisors | 47.33K | 0.00% | $89.92K |
| Bessemer group | 140.84K | 0.00% | $268.00K |
| Renaissance | 61.80K | 0.00% | $131.02K |
| Newedge advisors | 9.00K | 0.00% | $17.10K |
| Two sigma securities | - | - | - |
| Cibc world market | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bessemer group | 140.84K | 0.00% | 140.84K |
| Susquehanna group, llp | 38.40K | - | 17.74K |
| Geode capital management | 21.14K | - | 3.54K |
| Bank of america corp /de/ | 3.00K | - | 3.00K |
| Renaissance | 61.80K | 0.00% | 600.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perigon wealth management | - | - | -145.84K |
| Ubs group | - | - | -142.75K |
| Parkman healthcare partners | 355.82K | 0.08% | -83.81K |
| Virtu financial | - | - | -22.04K |
| Millennium management | - | - | -19.51K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bessemer group | 140.84K | 0.00% | 140.84K | $268.00K |
| Bank of america corp /de/ | 3.00K | - | 3.00K | $5.52K |
Sold Out
| Holder | Change |
|---|---|
| Jpmorgan chase | -2.00 |
| Royal bank of canada | -3.00K |
| Citadel advisors | -3.90K |
| Xtx topco | -10.86K |
| Cibc world market | -12.50K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 19 | -5.00% | 10,211,002 | -0.11% | 23 | 4.24% | 8 | -20.00% | 4 | 100.00% |
| Mar 31, 2025 | 20 | 25.00% | 10,222,258 | 36.10% | 23 | 5.92% | 10 | 42.86% | 2 | - |
| Dec 31, 2024 | 5 | -73.68% | 231,778 | -95.65% | - | 0.31% | 1 | -83.33% | 1 | -66.67% |
| Sep 30, 2024 | 19 | 35.71% | 5,323,228 | 0.57% | 14 | 6.81% | 6 | -14.29% | 3 | 50.00% |
| Jun 30, 2024 | 14 | -6.67% | 5,292,989 | 24.27% | 14 | 7.01% | 7 | -22.22% | 2 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Nasdaq Composite Index | 21.14K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 12, 2024 | Taitel Haya | - | Buy | $9.40K |
| Jan 10, 2024 | Taitel Haya | - | Buy | $5.86K |
| Dec 22, 2023 | LIEBERMAN GERALD M | - | Buy | $17.01K |
| Dec 22, 2023 | LIEBERMAN GERALD M | - | Buy | $23.95K |
| Dec 22, 2023 | Toledano Miranda Jayne | Chief Executive Officer | Buy | $17.01K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
ENTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools